These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10738861)

  • 21. The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia.
    Smith RC; Infante M; Singh A; Khandat A
    Int J Neuropsychopharmacol; 2001 Sep; 4(3):239-50. PubMed ID: 11669086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical symptom dimensions and deficits on the Continuous Performance Test in schizophrenia.
    Liu SK; Hwu HG; Chen WJ
    Schizophr Res; 1997 Jun; 25(3):211-9. PubMed ID: 9264176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained attention and positive formal thought disorder in schizophrenia.
    Pandurangi AK; Sax KW; Pelonero AL; Goldberg SC
    Schizophr Res; 1994 Sep; 13(2):109-16. PubMed ID: 7986767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic effects on neuropsychological test performance in schizophrenia.
    Verdoux H; Magnin E; Bourgeois M
    Schizophr Res; 1995 Jan; 14(2):133-9. PubMed ID: 7710993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficits in visual sustained attention differentiate genetic liability and disease expression for schizophrenia from Bipolar Disorder.
    Kumar CT; Christodoulou T; Vyas NS; Kyriakopoulos M; Corrigall R; Reichenberg A; Frangou S
    Schizophr Res; 2010 Dec; 124(1-3):152-60. PubMed ID: 20674278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained attention in mild Alzheimer's disease.
    Berardi AM; Parasuraman R; Haxby JV
    Dev Neuropsychol; 2005; 28(1):507-37. PubMed ID: 15992254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability in backward masking performance in schizophrenics, affectively disturbed patients, and normal subjects.
    Rund BR; Landrø NI; Orbeck AL
    J Nerv Ment Dis; 1993 Apr; 181(4):233-7. PubMed ID: 8473875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptics improve sustained attention in schizophrenia. A study using signal detection theory.
    Nestor PG; Faux SF; McCarley RW; Sands SF; Horvath TB; Peterson A
    Neuropsychopharmacology; 1991 Feb; 4(2):145-9. PubMed ID: 1673845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Event-related potentials in schizophrenic patients during a degraded stimulus version of the visual continuous performance task.
    Knott V; Mahoney C; Labelle A; Ripley C; Cavazzoni P; Jones B
    Schizophr Res; 1999 Feb; 35(3):263-78. PubMed ID: 10093872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.
    Yamashita H; Mori K; Nagao M; Okamoto Y; Morinobu S; Yamawaki S
    J Clin Psychiatry; 2004 Nov; 65(11):1525-30. PubMed ID: 15554767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reaction time and sustained attention in schizophrenia and its genetic predisposition.
    Birkett P; Sigmundsson T; Sharma T; Toulopoulou T; Griffiths TD; Reveley A; Murray R
    Schizophr Res; 2007 Sep; 95(1-3):76-85. PubMed ID: 17630256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do neuroleptics impair learning in schizophrenic patients?
    Cutmore TR; Beninger RJ
    Schizophr Res; 1990; 3(3):173-86. PubMed ID: 1980612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Missed targets, reaction times, and arousal are related to trait anxiety and attention to pain during an experimental vigilance task with a painful target.
    Emerson NM; Meeker TJ; Greenspan JD; Saffer MI; Campbell CM; Korzeniewska A; Lenz FA
    J Neurophysiol; 2020 Feb; 123(2):462-472. PubMed ID: 31596643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
    Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
    Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics.
    Roth WT; Goodale J; Pfefferbaum A
    Biol Psychiatry; 1991 Mar; 29(6):585-99. PubMed ID: 1675890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of atypical neuroleptics on alertness and visual orienting in stabilized schizophrenic patients: a preliminary study.
    Daban C; Krebs MO; Bourdel MC; Willard D; Loo H; Olié JP; Poirier MF; Amado I
    Int J Neuropsychopharmacol; 2004 Sep; 7(3):255-63. PubMed ID: 15050039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Everyday memory and laboratory memory tests: general function predictors in schizophrenia and remitted depression.
    Fennig S; Mottes A; Ricter-Levin G; Treves I; Levkovitz Y
    J Nerv Ment Dis; 2002 Oct; 190(10):677-82. PubMed ID: 12409861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive performance and basic symptoms in first-degree relatives of schizophrenic patients.
    Bove EA
    Compr Psychiatry; 2008; 49(4):321-9. PubMed ID: 18555050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
    Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
    Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.